APA (7th ed.) Citation

Kuo, C., Chen, C., Li, C., Huang, G., Ma, W., Hsu, W., . . . Wo, A. M. (2020). Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. Scientific Reports, N.PAG. https://doi.org/10.1038/s41598-020-68553-7

Chicago Style (17th ed.) Citation

Kuo, Chun-Ting, Chen-Lin Chen, Chih-Chi Li, Guan-Syuan Huang, Wei-Yuan Ma, Wei-Fan Hsu, Ching-Hung Lin, Yen-Shen Lu, and Andrew M. Wo. "Author Correction: Immunofluorescence Can Assess the Efficacy of MTOR Pathway Therapeutic Agent Everolimus in Breast Cancer Models." Scientific Reports 2020: N.PAG. https://doi.org/10.1038/s41598-020-68553-7.

MLA (9th ed.) Citation

Kuo, Chun-Ting, et al. "Author Correction: Immunofluorescence Can Assess the Efficacy of MTOR Pathway Therapeutic Agent Everolimus in Breast Cancer Models." Scientific Reports, 2020, p. N.PAG, https://doi.org/10.1038/s41598-020-68553-7.